Simulations Plus (FRA:SD3) Marketable Securities: €12.55 Mil (As of May. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:SD3 Simulations Plus Inc FRA:SD3
82 GF Score
Price €15.50
GF Value €29.72
! 7 Warning Signs
View Full Analysis

What is Simulations Plus Marketable Securities?

Simulations Plus FRA:SD3 -0.64% 82 Marketable Securities is €12.55 Mil as of May. 2026. GuruFocus rates FRA:SD3 with a GF Score™ of 82/100 and a GF Value™ of €29.72. The stock has 7 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Simulations Plus's Marketable Securities for the quarter that ended in May. 2026 was €12.55 Mil.

Simulations Plus's annual Marketable Securities declined from Aug. 2023 (€53.13 Mil) to Aug. 2024 (€9.02 Mil) and declined from Aug. 2024 (€9.02 Mil) to Aug. 2025 (€1.29 Mil).

Simulations Plus  (FRA:SD3) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Simulations Plus Marketable Securities Related Terms

Simulations Plus Marketable Securities Historical Data

* Premium members only.

The historical data trend for Simulations Plus's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Simulations Plus Marketable Securities Chart

Simulations Plus Annual Data
Trend Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24 Aug25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 73.63 75.67 53.13 9.02 1.29

Simulations Plus Quarterly Data
Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26 May26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.33 1.29 4.76 13.63 12.55
FRA:SD3
82GF Score
Simulations Plus Inc FRA:SD3
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Simulations Plus Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of €12.55 Mil mean?
Simulations Plus (FRA:SD3) has a Marketable Securities of €12.55 Mil as of May. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Simulations Plus and its competitors.
Is Simulations Plus' Marketable Securities too high?
Simulations Plus' current Marketable Securities is €12.55 Mil. Overall, Simulations Plus has a GF Score™ of 82/100, reflecting its overall financial health beyond just this single metric.
How does Simulations Plus' Marketable Securities compare to CTEV and TBRG?
Simulations Plus' Marketable Securities of €12.55 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Healthcare Providers & Services company?
A good Marketable Securities depends on the Healthcare Providers & Services industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Simulations Plus and its competitors. Simulations Plus's current Marketable Securities is €12.55 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Simulations Plus stock overvalued right now?
Simulations Plus (FRA:SD3) has a current Marketable Securities of €12.55 Mil. The stock's GF Value™ is €29.72, compared to a current price of €15.50 — trading 47.8% below its estimated fair value. The current Marketable Securities is €12.55 Mil. Simulations Plus' overall GF Score™ is 82/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Simulations Plus (FRA:SD3), the current Marketable Securities is €12.55 Mil as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Simulations Plus (FRA:SD3) Overvalued in 2026?

Based on GuruFocus' analysis, Simulations Plus stock appears to be undervalued. The current stock price of €15.50 is trading 47.8% below its estimated GF Value™ of €29.72.

Key valuation signals for FRA:SD3:

  • Marketable Securities: €12.55 Mil
  • GF Value™: €29.72 vs. price of €15.50 (47.8% below fair value)
  • GF Score™: 82/100 with 7 warning signs

No single metric tells the full story. See the FRA:SD3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Simulations Plus Business Description

Other Exchanges SLP:USA
Address 800 Park Offices Drive, Suite 401, Research Triangle Park, Lancaster, NC, USA, 27709
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.
82GF Score

Get the complete analysis for FRA:SD3

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€15.50
Price
€29.72
GF Value